Strategic partnership Opportunity: Omega Bio-tek collaboration already established, signaling receptiveness to automated workflows and potential for expanded joint solutions across high-throughput projects such as nucleic acid purification. Action: propose cross-sell of VVP-enabled Lynx platforms and custom OEM automation for Omega’s expanding instrument integrations.

High-value technology Opportunity: Volume Verified Pipetting (VVP) uniquely monitors all liquid handling volumetrically, offering strong ROI through accuracy and reduced contamination. Action: target labs with stringent regulatory and quality demands (clinical diagnostics, forensic, biobanking) for efficiency gains and compliance benefits.

Growing spend Opportunity: revenue in the mid single to mid double digits and a focused customer base implies potential for incremental deals with mid-market life science labs seeking scalable automated solutions. Action: pursue expansion deals with existing customers and leverage case studies to win new accounts in biotech, agbio, and clinical diagnostics.

Geographic reach Opportunity: multiple U.S. offices (Wilmington, Phoenix, Carlsbad) indicate national coverage and capability to support regional deployments, service, and training. Action: develop regional campaigns, on-site demonstrations, and local service agreements to accelerate adoption.

Consultative approach Opportunity: emphasis on listening to customers and tailored solutions positions Dynamic Devices to upsell modular automation, custom OEM solutions, and workflow optimization services. Action: offer end-to-end workflow assessments, pilot deployments, and expanded hardware integration with existing lab infrastructure.